DE3582791D1 - Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel. - Google Patents

Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel.

Info

Publication number
DE3582791D1
DE3582791D1 DE8585114935T DE3582791T DE3582791D1 DE 3582791 D1 DE3582791 D1 DE 3582791D1 DE 8585114935 T DE8585114935 T DE 8585114935T DE 3582791 T DE3582791 T DE 3582791T DE 3582791 D1 DE3582791 D1 DE 3582791D1
Authority
DE
Germany
Prior art keywords
plipastatin
production
medicinal product
ala
immunosuppressive compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585114935T
Other languages
German (de)
English (en)
Inventor
Hamao Umezawa
Takaaki Aoyagi
Tomio Takeuchi
Masa Hamada
Hiroshi Naganawa
Yasuhiko Muraoka
Takaaki Nishikiori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Application granted granted Critical
Publication of DE3582791D1 publication Critical patent/DE3582791D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/085—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
DE8585114935T 1984-12-06 1985-11-26 Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel. Expired - Lifetime DE3582791D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59256475A JPS61134398A (ja) 1984-12-06 1984-12-06 新生理活性物質プリパスタチン及びその製造法

Publications (1)

Publication Number Publication Date
DE3582791D1 true DE3582791D1 (de) 1991-06-13

Family

ID=17293148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585114935T Expired - Lifetime DE3582791D1 (de) 1984-12-06 1985-11-26 Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel.

Country Status (13)

Country Link
US (1) US4742155A (enExample)
EP (1) EP0192828B1 (enExample)
JP (1) JPS61134398A (enExample)
KR (1) KR920006881B1 (enExample)
AT (1) ATE63318T1 (enExample)
AU (1) AU583553B2 (enExample)
DE (1) DE3582791D1 (enExample)
DK (1) DK564785A (enExample)
ES (1) ES8701197A1 (enExample)
GR (1) GR852894B (enExample)
HU (1) HU193838B (enExample)
PT (1) PT81615B (enExample)
ZA (1) ZA859315B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217952A (en) * 1988-02-02 1993-06-08 Fujisawa Pharmaceutical Co., Ltd. Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
US5436140A (en) * 1988-02-02 1995-07-25 Fujisawa Pharmaceutical Co., Ltd. Process for producing WS-9326A and WS-9326B
IN167138B (enExample) * 1988-08-17 1990-09-01 Hoechst India
US5619066A (en) * 1990-05-15 1997-04-08 Dallas Semiconductor Corporation Memory for an electronic token
DE69229173T2 (de) * 1991-07-04 1999-09-16 Garvan Institute Of Medical Research, Darlinghurst Pla2 hemmende verbindungen
PL198772B1 (pl) * 1997-05-09 2008-07-31 Agraquest Biologicznie czysta kultura Bacillus subtilis, jej metabolit i supernatant z hodowli szczepu, kompozycje do ochrony roślin i owoców przed szkodnikami, sposób ochrony lub leczenia roślin i owoców, agrastatyny, sposób izolowania supernatantu o aktywności owadobójczej
CN117683074B (zh) * 2023-12-13 2024-08-16 山东绿邦生物科技有限公司 蜡样芽孢杆菌、蛋白酶抑制剂以及提高蛋白渣产量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201771A (en) * 1979-03-12 1980-05-06 Merck & Co., Inc. Antibiotic A43F

Also Published As

Publication number Publication date
ZA859315B (en) 1986-10-29
ES8701197A1 (es) 1986-11-16
HUT40707A (en) 1987-01-28
JPS61134398A (ja) 1986-06-21
US4742155A (en) 1988-05-03
EP0192828B1 (en) 1991-05-08
KR860005027A (ko) 1986-07-16
EP0192828A3 (en) 1988-06-01
EP0192828A2 (en) 1986-09-03
KR920006881B1 (ko) 1992-08-21
GR852894B (enExample) 1986-04-01
ES549565A0 (es) 1986-11-16
HU193838B (en) 1987-12-28
DK564785A (da) 1986-06-07
PT81615B (pt) 1988-02-17
AU583553B2 (en) 1989-05-04
DK564785D0 (da) 1985-12-05
ATE63318T1 (de) 1991-05-15
PT81615A (en) 1986-01-01
AU5030785A (en) 1986-06-12

Similar Documents

Publication Publication Date Title
DE3587579D1 (de) Pharmazeutische Zubereitung enthaltend eine Tetrahydropyrrolverbindung als aktiven Bestandteil und Verfahren zur Herstellung dieser Tetrapyrrolverbindung.
DE3588095D1 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
NO955219D0 (no) Nye kjemiske forbindelser med PDE-IV-inhiberende aktivitet
DE59005254D1 (de) 24-Homo-Vitamin-D-Derivate, Verfahren zu ihrer Herstellung; diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung als Arzneimittel.
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
DE3582791D1 (de) Immunosuppressive verbindungen, deren mikrobiologische verfahren zur herstellung und deren verwendung als arzneimittel.
RO86647A (ro) Procedeu pentru prepararea unor derivati de 4''-epieritromicina
ES8602725A1 (es) Procedimiento de preparacion de bencensulfonamidas y similares.
GB1528259A (en) Process for the preparation of a gamma-globulin solution suitable for intravenous administration
YU43528B (en) Process for obtaining 4-phenyl quinazoline derivatives
ATE44743T1 (de) 4-oxo-pyrido(2,3>pyrimidin-derivate, verfahren zur deren herstellung und diese ethaltende arzneimittel.
IL70082A (en) Pharmaceutical compositions comprising 1-aroyl-5-oxo-2-pyrrolidinopropanoic acids and salts and esters thereof,certain such compounds and their preparation
Davis et al. Synthesis and microbiological properties of some substituted derivatives of 3-amino-3, 4-dihydrocarbostyril
Yajima et al. Studies on Peptides. IX. Synthesis of N-(Histidylphenylalanylarginy1)-5-methoxytryptamine, an Inhibitor of α-Melanocyte-stimulating Hormone in virto
EP0387677A3 (en) Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
Hegedüs et al. A sensitive assay for the pharmacokinetic investigation of a rapidly hydrolyzing alkylating agent lycurim®(Ritrosulfan; R-74; NSC-122 402)
ATE100807T1 (de) Thienylpiperazine, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung.
MD675B2 (en) The cobalt's complexes with antimicrobic activity and process for manufacturing of them
矢島治明 et al. Studies on Peptides. IX. Synthesis of N-(Histidylphenylalanylarginy1)-5-methoxytryptamine, an Inhibitor of α-Melanocyte-stimulating Hormone in virto
KR890014745A (ko) Fr-900493화합물과 그 제조방법 및 그를 함유한 의약조성물
DE2539800A1 (de) Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
RU94045895A (ru) Пептиды лактама, обладающие ингибирующей активностью в отношении hle
NO945091L (no) Fluorholdige dipeptider som inhibitorer mot menneske-leukocyt-elastase-inhibitorer
DK214884D0 (da) Chlorphenoxyacetatderivat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee